60 Degrees Pharmaceuticals 宣布,其用于治疗住院巴贝斯虫病患者的他非诺喹临床试验,已提前完成首位季节性患者的入组工作。
60 Degrees Pharmaceuticals 宣布,其用于治疗住院巴贝斯虫病患者的他非诺喹临床试验,已提前完成首位季节性患者的入组工作。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.